大发棋牌官网登录

search for

/ English Chinese / English

Copyright: Shenzhen Kangtai Biological Products Co., Ltd. Address: No. 6 Kefa Road, Science and Technology Park, Nanshan District, Shenzhen Telephone: 86-755-26988688
Guangdong ICP No. 06026377     office@siip.com.cn 销售服务热线:400-880-6992 网站建设: 中企动力 Fax: 86-755-26988600 Email: office@siip.com.cn Sales Service Hotline: 400-880-6992 Website Construction: www.300.cn Beijing

30 years of development

三十年 历程的生物医药领域公司 A company in the biomedical field after 30 years

Broad sales coverage

Engaged in the research and development of vaccines in the field of biomedicine

A health-oriented modern science and technology enterprise, an international vaccine company striving to build the Great Wall of National Health Protection, owning the first domestic quadruple vaccine with independent intellectual property rights, and grasping the commanding heights of the world's leading-edge vaccine technology. There are 25 vaccine projects under development, of which 5 have applied for national drug production registration approval, 11 have obtained clinical approval, 1 has applied for clinical research, and 8 are undergoing preclinical research. The company is located in No. 6 Kefa Road, Science and Technology Park, Nanshan District, Shenzhen, with a registered capital of 634 million yuan

Management advantage

Quality management covers the entire process from product development, trial production, raw and auxiliary materials procurement, product production process, inspection, storage and shipment of finished products

The company has strong technical strength, has a domestic leading new vaccine and multivalent vaccine research and development center, is one of the first batch of national high-tech enterprises

Technical advantages

The registered capital is 634 million yuan. It has two major R & D and production bases in Shenzhen Science and Technology Park and Beijing. The Shenzhen Bright Vaccine R & D and Production Base will soon be put into use. The R & D center covers an area of more than 5,000 square meters and has various purification and verification equipment.

Resource advantage

Team Advantage

The company has more than 100 full-time R & D personnel, of which many core technical personnel participate in multiple "863" national key research projects

news
Industry Information
Social responsibility
Carrying on social responsibilities, embodying special responsibilities, and helping scientific prevention and control—Shenzhen speeds up scientific research and runs out of the “war epidemic” acceleration

Carrying on social responsibilities, embodying special responsibilities, and helping scientific prevention and control—Shenzhen speeds up scientific research and runs out of the “war epidemic” acceleration

2020-02-17
Shenzhen Enterprises Featured "News Broadcast"

Shenzhen Enterprises Featured "News Broadcast"

2020-02-17
Taking on the task of research and development of the new crown pneumonia vaccine, Shenzhen Enterprise's subsidiary appeared on CCTV "News Broadcast"

Taking on the task of research and development of the new crown pneumonia vaccine, Shenzhen Enterprise's subsidiary appeared on CCTV "News Broadcast"

2020-02-17
Kangtai Biological speeds up vaccine research and development

Kangtai Biological speeds up vaccine research and development

2020-02-17
`` Newscast '' walks into Kangtai Bio: speeding up vaccine development

`` Newscast '' walks into Kangtai Bio: speeding up vaccine development

2020-02-13
23 valence pneumococcal vaccine adds a new army, Guangdong province completes first vaccination in Huadu

23 valence pneumococcal vaccine adds a new army, Guangdong province completes first vaccination in Huadu

2019-11-05
Hepatitis B "10 Questions": Hepatitis B vaccine encounters "accident", what should I do?

Hepatitis B "10 Questions": Hepatitis B vaccine encounters "accident", what should I do?

2019-10-08
To understand the 23-valent pneumococcal polysaccharide vaccine, it is enough to read this

To understand the 23-valent pneumococcal polysaccharide vaccine, it is enough to read this

2019-08-15
China's first vaccine management law passed

China's first vaccine management law passed

2019-06-29
Hepatitis B antibodies disappear, how to make the vaccine more effective?

Hepatitis B antibodies disappear, how to make the vaccine more effective?

2019-03-04

年6月16日,康泰生物向青海杂多县捐赠320万元疫苗物资。 On June 16, 2017 , Kangtai Bio donated 3.2 million yuan of vaccine supplies to Zaduo County, Qinghai.